SavedAdd your journal

Journals / Bozok Tıp Dergisi / 2026 / Cilt: 5 Sayı: 1

PEDİATRİK ŞANT ENFEKSİYONLARI: 105 OLGULUK ÇİFT MERKEZLİ ÇALIŞMA

İsmail Gülşen
Hakan Ak
Abdurrahman Aycan,
Tugay Atalay
Enver Sösuncu
Mehmet Edip Akyol
Fethullah Kuyumcu
Mehmet Arslan
Pages
13–17
Publication Date
2015-02-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean duration of treatment was 31 (min 21-max 90) days

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ventriculoperitoneal shunt infection is an important cause of morbidity and mortality in patients with hydrocephalus.
📊
Key Findings & Data:If not diagnosed promptly and treated appropriately, mortality rates may be as high as 40%.
💡
Conclusion & Impact:Mean duration of treatment was 31 (min 21-max 90) days
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Hidrosefali · Ventiriküloperitoenal şant · Stafilokokkus epidermidis

Abstract

Ventriculoperitoneal shunt infection is an important cause of morbidity and mortality in patients with hydrocephalus. If not diagnosed promptly and treated appropriately, mortality rates may be as high as 40%. Herein, 105 patients with ventriculoperitoneal shunt infections operated in two different health centers were reviewed retrospectively. Demographic data, medical history, physical examination findings, laboratory findings, causative agents, and tertament modalities were noted. It was detected that shunt infection had been developed in 183 (min-max: 4-1080 days). Staphylococcus epidermidis was the most common pathogenic agent (40.5%). Mean duration of treatment was 31 (min 21-max 90) days

Özet

ÖZET Ventriküloperitoneal şant enfeksiyonu hidrosefali hastalarında önemli bir morbidite ve mortalite nedenidir. Hızlı tanı konulup uygun şekilde tedavi edilmediği takdirde %40’lara kadar varan mor- talite oranları görülebilir. Bu yazıda iki farklı merkezde şant enfeksiyonu nedeniyle tedavi edilen 105 olgu retrospektif olarak incelendi. Bu olgulara ait demografik veriler, klinik öyküleri, muayene bulguları, laboratuvar bulguları, enfeksiyon nedeni olan mikrobik ajan ve tedavi şekilleri not edildi. Hastalarımızda şant enfeksiyonu ortalama 183 gün içinde (min-max: 4-1080 gün) gelişmiştir. En sık izole edilen ajan stafilokkus epidermidis (%40,5) olarak saptandı. Hastaların ortalama tedavi süresi 31 gün (min 21-max 90 gün) olarak tespit edildi. Anahtar kelimeler: Hidrosefali; Ventiriküloperitoenal şant; Stafilokokkus epidermidis ABSTRACT Ventriculoperitoneal shunt infection is an important cause of morbidity and mortality in patients with hydrocephalus. If not diagnosed promptly and treated appropriately, mortality rates may be as high as 40%. Herein, 105 patients with ventriculoperitoneal shunt infections operated in two different health centers were reviewed retrospectively. Demographic data, medical history, physical examination findings, laboratory findings, causative agents, and tertament modalities were noted. It was detected that shunt infection had been developed in 183 (min-max: 4-1080 days). Staphylococcus epidermidis was the most common pathogenic agent (40.5%). Mean duration of treatment was 31 (min 21-max 90) days. Key words: Hydrocephalus; Ventriculoperitoneal shunt; Staphylococcus epidermidis

🔖

Cite This Article

Gülşen, İ., Ak, H., Aycan, A., Atalay, T., Sösuncu, E., Akyol, M. E., Kuyumcu, F., Arslan, M. (2015). PEDİATRİK ŞANT ENFEKSİYONLARI: 105 OLGULUK ÇİFT MERKEZLİ ÇALIŞMA. Bozok Tıp Dergisi, Cilt: 5 Sayı: 1, 13–17. https://ajindex.com/articles/1377972

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Çataltepe O. Hidrosefali: Sınıflama, patofizyoloji, klinik ve tedavi. In Aksoy K. Temel Nöroşirurji Cilt 2. Birinci Baskı. Ankara Buluş Tasarım ve Matbaacılık Hizmetleri. 2005 s. 1446-1454.
  2. Amirati M, Raimondi A. Cerebrospinal fluid shunt infections in children: A study of the relatonship between the etiology of the hydrocephalus, age at the time of shunt placement, and infection. Childs Nerv Syst. 1987;3 (2):106-9.
  3. Choux M, Genitori L, Lang D, Lena G. Shunt implantation reducing the incidence of shunt infection. J Neurosurg. 1992;77(6):875-80.
  4. Zemack G, Romner B. Seven years clinical experience. J Neurosurg. 2000;92 (6): 941-8.
  5. Chagman PH: Shunt infections: prevention and treatment. Clin Neurosurg. 1985; 32 (1): 625-64.
  6. Ronan A, Hogg GG, Klug GL. Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J. 1995; 14 (9): 782
  7. Piatt JH, Carlson CV. A search for determinants of cerebrospinal fluid shunt survival: A retrospective analysis of 14 year institutional experience. Pediatr Neurosurg. 1993; 19 (4):233-42.
  8. Reddy GK, Bollam P, Caldito G. Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: Long-term single institution experience. World Neurosurg. 2012; 78(1-2):155-63.
  9. Erşahin Y. Beyin Omurilik sıvısı şant enfeksiyonları. Türk Noroşirurji Dergisi. 1999; 9 (1):12-20.
  10. Kulkarni AV, Drake JM. Cerebrospinal fluid shunt infection: A prospective study of risk factors. J Neurosurg. 2001; 94 (2):195-201.
  11. Çocukluk çağında ventriküloperitoneal şant disfonksiyonları. Gülşen İ, Ak H, Arslan M, Gökalp A, Sösuncu E, Kıymaz N. Çocukluk çağında ventriküloperitoneal şant disfonksiyonları. Türk Nöroşirurji Dergisi. 2014; 24 (3): 280-3.
  12. Odio C, McCracken GH, Nelson JD. CSF shunt infections in pediatrics: a seven year experience. Am J Dis Child. 1984; 138 (12):1103-8.
  13. Turgut M, Alabaz D, Erbey F, Kocabaş E, Erman T, Alhan E, Aksaray N. Cerebrospinal fluid shuntinfections in children. Pediatr Neurosurg. 2005; 41 (3): 131-6.
  14. Çağan E,Soysal A, Şeker A, Şeker M. Çocuklarda Ventriküloperitoneal Şant Enfeksiyonları ve Tedavisi. Cukurova Medical Journal. 2015;40(1):72-9.
  15. Prusseit J, Simon M, von der Brelie C, Heep A, Molitor E, Volz S, Simon A. Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr. Neurosurg. 2009; 45 (5): 325-36.
  16. Odabaşı Z. Santral Sinir sistemi Enfeksiyonları. Yoğun Bakım Dergisi. 2005; 3(1):58-64.
  17. Kaufman BA,Tunkel AR, Pryor JC,Dacey RG Jr. Meningitis in the neurosurgical patient. Infect Dis Clin North Am. 1990 4(4):677-701.